Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07432360

Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology

Bridging Imaging and Pathology: Using Advanced MRI Protocols in Correlation With Extensive Histopathology to Detect Clinically Significant Prostate Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Virdx, Inc. · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

In recent years, new and promising approaches have emerged in the field of MRI imaging of the prostate. These approaches usually aim to visualise the so-called "microstructures" of the tissue and are intended to offer greater accuracy in the diagnosis of prostate cancer than the current mpMRI examination. To this end, mathematical microstructure models are calculated that determine the proportional presence of histological substructures in specific MRI volumes. Additional new MRI sequences that are not routinely recorded are required to calculate the microstructure models. In order to further investigate the possibilities of these new MRI sequences, this study will compare different mathematical models. In addition, a histopathological examination of the tissue will be performed.

Conditions

Timeline

Start date
2026-01-28
Primary completion
2028-06-01
Completion
2028-06-01
First posted
2026-02-25
Last updated
2026-02-25

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT07432360. Inclusion in this directory is not an endorsement.